Savonix to Present at Upcoming Industry & Scientific Conferences

a global leader in digital tests for cognitive health, announced today
that the Company will be presenting at the upcoming conferences:

Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019

  • Poster Presentation: Improving Dementia Economics Through Earlier
    Cost-Effective Assessment
  • Research Poster Presentations – Session 2
  • Study authors: Dr. Kevin Carroll, Dr. Jim McCollum, Dr. Mylea Charvat
  • Presenter: Dr. Kevin Carroll, US Clinical Director, Savonix
  • May 20, 3:30 PM – 7:00 PM, Poster Author Discussion Hour: 6:00 PM –
    7:00 PM
  • New Orleans Ernest N. Morial Convention Center, New Orleans, LA

Dr. Mylea Charvat, CEO and Founder of Savonix will be speaking at the
following conferences:


  • Brain Health Panel: Beyond Dementia: The REALLY Big Opportunities in
  • Jun 4, 11:00 AM – 12:15 PM ET
  • Philadelphia Convention Center, 116, Level 100

CEO Initiative on Alzheimer’s Disease (CEOi)
and Ministry of
Economy, Trade and Industry of Japan (METI) Roundtable Discussion on
Brain Health

  • Presentation: Scaling Support through Technology
  • June 5, 2:00 – 5:00 PM
  • AARP Global Headquarters, 601 E Street, NW, Washington, DC

Insurtech Leaders Summit

  • Panel: What Insurance Innovation for Longevity and Aging Means?
  • June 19, 12:35 – 1:15 PM
  • One Liberty Plaza, New York, NY

Women in Tech Conference 2019

  • Panel: Male Allies: The Role of Male Allies in the Success of Women’s
    Careers: Being and Securing Male Allies as Mentors, Collaborators, &
  • June 20, 2:00 PM – 6:30 PM
  • SAP Palo Alto, 3410 Hillview Avenue, Palo Alto, CA

Capital Annual Meeting (closed to press)

  • Japan focused Roundtable on Dementia
  • July 18, 1:00 PM – 6 PM / July 19, 9:00 AM – 5:00 PM
  • San Mateo Marriott, 1770 S Amphlett Blvd, San Mateo, CA

About Savonix

Savonix delivers a fully mobile assessment of cognitive function
available on Android and iOS for phone and tablet, the Savonix Cognitive
Assessment platform is an accurate, accessible and affordable tool for
professional cognitive screens. It empowers healthcare providers, payers
and researchers to evaluate and leverage results to improve health and
treatment outcomes. Led by clinical neuropsychologists and digital
health technology experts, the company has established itself as an
authority on cognition globally. To learn more about Savonix, visit


Kimberly Ha
KKH Advisors
[email protected]

error: Content is protected !!